Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Cardiac sympathetic over-activity is a well-established contributor to the progression of neurogenic hypertension and heart failure, yet the underlying pathophysiology remains unclear. Recent studies have highlighted the importance of acutely regulated cyclic nucleotides and their effectors in the control of intracellular calcium and exocytosis. Emerging evidence now suggests that a significant component of sympathetic over-activity and enhanced transmission may arise from impaired cyclic nucleotide signalling, resulting from compromised phosphodiesterase activity, as well as alterations in receptor-coupled G-protein activation. In this review, we address some of the key cellular and molecular pathways that contribute to sympathetic over-activity in hypertension and discuss their potential for therapeutic targeting. This article is protected by copyright. All rights reserved.

Original publication

DOI

10.1113/jp276962

Type

Journal article

Journal

The Journal of physiology

Publication Date

11/10/2018

Addresses

Wellcome Trust OXION Initiative in Ion Channels and Disease, Oxford, UK.